Harbinger Health raises $100M for new suite of blood-based cancer detection tests
Harbinger Health has secured $100 million in its latest funding round, unveiling its new Resolve platform aimed at enhancing cancer detection through li…
Longevity science decoded daily
Curated coverage of healthspan research, longevity therapeutics, and the science of living longer — tracked through the signals that matter.
968
Articles
11
Signals
5
Topics
April 14, 2026
Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease
Anavex Life Sciences Corp. has revealed significant findings supporting the mechanistic rationale for its orally administered drug, blarc...
Read more →Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress
Tiziana Life Sciences has announced the acceptance of a late-breaking poster detailing its Phase 2a study of intranasal foralumab, a full...
Read more →Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan) in FSGS
Ligand Pharmaceuticals has announced that its partner, Travere Therapeutics, has received FDA approval for FILSPARI® (sparsentan), the fi...
Read more →The Senescence Associated Secretory Phenotype as a Basis for an Aging Clock
Researchers have developed a composite SASP Score that quantifies the burden of senescent cells in the body by analyzing proteomic data f...
Read more →An Approach to Reduce Harmful Inflammation without Greatly Compromising the Normal Immune Response
Researchers at Scripps Research have identified a novel approach to mitigate chronic inflammation associated with autoimmune diseases and...
Read more →Asgard Therapeutics appoints Professor Dr Wolfram Brugger as Chief Medical Officer as it advances transformative ‘personalized off-the-shelf’ immunotherapy toward clinical development
Asgard Therapeutics has announced the appointment of Prof. Dr. Wolfram Brugger as Chief Medical Officer, signaling a strategic move to ad...
Read more →Renaissance Pharma Limited, an Essential Pharma company, secures FDA Fast Track Designation and IND clearance for Daretabart (hu1418K322A) in high-risk neuroblastoma
The FDA has granted Fast Track Designation to Daretabart (hu1418K322A), a novel anti-GD2 monoclonal antibody developed by Renaissance Pha...
Read more →PannTheraPi Announces Significant Clinical Development and Strategic Milestones
PannTheraPi has filed a regulatory submission to initiate a Phase 2a trial for its drug candidate PTI5803, targeting focal cortical dyspl...
Read more →PannTheraPi annonce des avancées majeures dans son développement clinique et stratégique
PannTheraPi has made significant strides in its clinical and strategic development, highlighted by the submission of a regulatory dossier...
Read more →April 13, 2026
Ballad Health’s program for assisting uninsured patients earns national award for its community-based approach to serving rural Appalachia
**Ballad Health’s Appalachian Highlands Care Network has been awarded the Innovators Award by Modern Healthcare for its transformative ap...
Read more →XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset
XORTX Therapeutics has successfully acquired the VB4-P5 renal anti-fibrotic program from Vectus Biosystems, a move that positions the com...
Read more →Les données intermédiaires de l'essai pivot testant cema-cel mettent en évidence la solidité de la plateforme CAR-T allogénique de Cellectis
Cellectis has highlighted the interim futility analysis from Allogene Therapeutics regarding the pivotal ALPHA3 trial, which evaluates ce...
Read more →Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform
Cellectis has announced significant interim results from Allogene Therapeutics’ pivotal ALPHA3 trial evaluating cema-cel, an allogeneic C...
Read more →Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451
Sana Biotechnology, Inc. has announced a strategic collaboration with Mayo Clinic to expedite the development of SC451, a hypoimmune-modi...
Read more →Revolution Medicines, Inc. Announces Proposed Offerings of Common Stock and Convertible Senior Notes
Revolution Medicines has announced a dual public offering aimed at raising $1 billion through $750 million in common stock and $250 milli...
Read more →Kailera outlines plans for $528.5M IPO to support quartet of Chinese obesity assets
Kailera is poised to enter the public market with a Nasdaq IPO aimed at raising up to $528.5 million to further develop its GLP-1 assets ...
Read more →Celebrating National Medical Laboratory Week
LifeLabs, a prominent provider of medical diagnostic services in Canada, is celebrating National Medical Laboratory Week (NMLW) by emphas...
Read more →Evidence for Retrotransposon Suppression to Reduce Biological Age in Humans
A recent study highlights the potential of nucleoside reverse transcriptase inhibitors (NRTIs), originally developed for HIV treatment, t...
Read more →Longevity market to hit $67b by 2035 due to rising aging concerns
The longevity market is undergoing a significant transformation, with projections indicating growth from $27.61 billion in 2025 to $67.03...
Read more →Alzheon pushes oral Alzheimer’s pipeline forward
Alzheon has initiated Phase 1 trials for ALZ-507, a next-generation oral drug candidate aimed at slowing the progression of Alzheimer’s d...
Read more →Function acquires Getlabs to scale at-home testing
Function’s acquisition of Getlabs marks a pivotal shift in healthcare delivery, enhancing the accessibility of health data by transformin...
Read more →Parkinson’s drug may backfire, study finds
A recent study from Yale School of Medicine, published in Nature Microbiology, reveals that COMT inhibitors—commonly prescribed to enhanc...
Read more →Women-only longevity retreat debuts in Bali
Goddess Retreats has launched a women-only longevity retreat in Bali, focusing on functional longevity through a seven-day health program...
Read more →Dermatology Devices Market to Reach $25.6 Billion by 2030, Driven by Rising Skin Cancer Incidence and Aesthetic Demand
The global dermatology devices market is projected to grow from $14.4 billion in 2024 to $25.6 billion by 2030, reflecting a robust **com...
Read more →ASK4SAM NYC Medical Malpractice Attorneys Silberstein & Miklos, P.C. Expands Focus on Representing Patients Across Manhattan, Brooklyn and Queens
Silberstein & Miklos, P.C., a New York City law firm, is intensifying its efforts to represent patients affected by medical malpracti...
Read more →Why Fast-Cycling Skin Cells Decrease With Age
Researchers have identified fibulin-5 as a critical protein in maintaining populations of fast-cycling skin stem cells, which decline wit...
Read more →Subcellular orchestration of microglial aging
Henze et al. have advanced our understanding of microglial aging by employing multiplexed error-robust fluorescence in situ hybridization...
Read more →Positive Phase 2 data show Solengepras benefits in Parkinson’s
Cerevance is set to present Phase 2 data for Solengepras (CVN424), a novel non-dopaminergic GPR6 inhibitor, at the upcoming **American Ac...
Read more →Longevity market projected to hit $67 billion by 2035
Research by SNS Insider projects the global longevity market will grow from USD 27.61 billion in 2025 to USD 67.03 billion by 2035, refle...
Read more →Mesoblast receives IND clearance to proceed to registrational trial
Mesoblast has received Investigational New Drug (IND) clearance from the FDA to advance Ryoncil (remestemcel-L-rknd) into a registrationa...
Read more →American Kidney Fund Announces 2026 Class of Corporate Members Supporting Work to Fight Kidney Disease
The American Kidney Fund (AKF) has announced its 2026 Class of Corporate Members, which includes prominent biotech and pharmaceutical com...
Read more →Eisai to present Lecanemab data at AAN meeting
Eisai Inc. is set to unveil new findings on Lecanemab at the upcoming 78th American Academy of Neurology Annual Meeting, scheduled for Ap...
Read more →Microcap produces anti-aging protein from encapsulated cells
Avaí Bio, in collaboration with Austrianova, is set to unveil findings from their α-Klotho anti-aging program at the upcoming Second Annu...
Read more →APLMS and Kitalys to Host Healthy Longevity in Hong Kong
The 2026 Asia-Pacific Healthy Longevity International Summit (APAC-LMIS) will take place in Hong Kong from October 1-4, 2026, organized b...
Read more →Regeneron rides into radiopharma via $2.1B biobucks pact with Australia’s Telix
Regeneron Pharmaceuticals has announced a strategic partnership with Telix Pharmaceuticals, committing $40 million upfront to advance fou...
Read more →Biotech Giants and Investors Gather to Solve the Commercialisation Puzzle This May in Hong Kong
The Asia Summit on Global Health (ASGH), scheduled for May 11-12, 2026, in Hong Kong, aims to tackle critical commercialization challenge...
Read more →New toothpaste stops gum disease without killing good bacteria
Researchers at the Fraunhofer Institute for Cell Therapy and Immunology have developed a groundbreaking toothpaste that effectively comba...
Read more →Men and women with obesity face very different hidden health risks
New findings from a study presented at the European Congress on Obesity reveal significant sex-based differences in how obesity manifests...
Read more →PolyPid to Present New Phase 3 SHIELD II Data Demonstrating D-PLEX₁₀₀ Sustained Local Release at ESCMID Global 2026
PolyPid Ltd. has unveiled promising pharmacokinetic data from its Phase 3 SHIELD II trial of D-PLEX₁₀₀, a novel local antibiotic delivery...
Read more →Free Oral Cancer Screenings in Honor of Oral, Head and Neck Cancer Awareness Month
U.S. Oral Surgery Management (USOSM) is launching a nationwide initiative to provide free oral cancer screenings from April 13 to 17, 202...
Read more →Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners
Neuronetics, Inc. has announced a significant policy update from Optum/United Healthcare/United Behavioral Health, which now allows psych...
Read more →Nanox Signs Distribution Agreement with Digital X-Ray Imaging to Expand Nanox.ARC Adoption in Arkansas
Nano X Imaging Ltd. has made significant strides in expanding its U.S. commercial presence with a new distribution agreement between its ...
Read more →NorthStrive Biosciences Announces U.S. Arrival of EL-32 Working Cell Bank and Initiation of Manufacturing Optimization for Dual Myostatin Assets Targeting Muscle Preservation with GLP-1 Therapies in Collaboration with Modulant Biosciences
NorthStrive Biosciences Inc. has achieved a significant milestone with the transfer of its EL-32 Working Cell Bank (WCB) to a U.S.-based ...
Read more →Spyre Announces Potential Best-in-Class SPY001 Part A Induction Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients
Spyre Therapeutics has announced promising results from the Phase 2 SKYLINE trial of SPY001, an investigational anti-α4β7 antibody design...
Read more →OXB launches fast-track offering for AAV and lentiviral vector platforms, accelerating viral vector development and manufacture
OXB has launched a fast-track development and manufacturing service aimed at biotechs facing timeline constraints, significantly accelera...
Read more →Ocular Therapeutix™ Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI™ in Wet AMD
Ocular Therapeutix has presented compelling post-hoc analyses from the SOL-1 Phase 3 trial of AXPAXLI (OTX-TKI) at the 14th Annual Vit-Bu...
Read more →Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral STAT6 Degrader for the Treatment of Moderate to Severe Asthma
Kymera Therapeutics has received Fast Track designation from the FDA for its investigational oral drug, KT-621, a first-in-class STAT6 de...
Read more →ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules
ANI Pharmaceuticals, Inc. has launched Carbamazepine Extended-Release Capsules in 100 mg, 200 mg, and 300 mg dosages, marking a significa...
Read more →Lilly's Jaypirca (pirtobrutinib) significantly extended progression-free survival when added to a venetoclax time-limited regimen in patients with previously treated CLL/SLL
Lilly’s Jaypirca (pirtobrutinib) has demonstrated a significant extension in progression-free survival (PFS) when combined with a venetoc...
Read more →An Attempt to Obtain Data on Longevity Effects of Human Psilocybin Use
A recent investigation into the longevity effects of psilocybin use among humans highlights the complexities of translating findings from...
Read more →Exoproteome of calorie-restricted humans identifies complement deactivation as an immunometabolic checkpoint reducing inflammaging
In a recent study from the CALERIE trial, researchers applied proteomics to plasma samples from participants who achieved an average of 1...
Read more →Reviewing What is Known of Sex Differences in Response to Established Longevity Interventions
Research highlights significant sex differences in response to longevity interventions, emphasizing the need for tailored approaches. A c...
Read more →Scientists were wrong about lifespan. Your genes matter way more than we thought
A groundbreaking study from the Weizmann Institute of Science has redefined the genetic contribution to human lifespan, revealing that ge...
Read more →Epitopea Strengthens Scientific Advisory Board with Appointment of Leading Authority in Cancer, Lisa Butterfield
Epitopea has appointed Dr. Lisa Butterfield to its Scientific Advisory Board, enhancing its leadership in the development of RNA-based im...
Read more →Epitopea renforce son comité consultatif scientifique avec la nomination de Lisa Butterfield, figure de renom dans le domaine du cancer
Epitopea has appointed Dr. Lisa Butterfield to its Scientific Advisory Board, enhancing its expertise in cancer immunotherapy as it advan...
Read more →Boehringer Ingelheim introduces LENZELTA®: A new vaccine advancing mastitis prevention in dairy cows
Boehringer Ingelheim has introduced LENZELTA®, a novel vaccine designed to significantly reduce the incidence and severity of clinical ma...
Read more →SynOx Therapeutics Announces Positive Topline Results from the Phase 3 TANGENT Study, Supporting Emactuzumab as a Differentiated, Next-generation Treatment for Patients with Tenosynovial Giant Cell Tumor (TGCT)
The TANGENT study has demonstrated that emactuzumab, a targeted CSF-1R inhibitor, meets its primary and secondary endpoints with high sta...
Read more →Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)
The European Commission has approved Dupixent® (dupilumab) for the treatment of moderate-to-severe chronic spontaneous urticaria (CSU) in...
Read more →Data Published in Nature Communications Highlights Unique Mechanism of Action of Alpibectir in Combination with Ethionamide (AlpE)
BioVersys, in collaboration with GSK and academic partners, has published pre-clinical data in Nature Communications on AlpE, a novel dru...
Read more →Forget daily pills. This shot works when blood pressure meds fail
A recent study from Queen Mary University of London has demonstrated that zilebesiran, an investigational drug, can significantly enhance...
Read more →Stanford scientists discover “natural Ozempic” without side effects
Scientists at Stanford Medicine have identified a novel peptide, BRP, that mimics the appetite-suppressing effects of semaglutide (Ozempi...
Read more →April 12, 2026
Scrap the Ban, Keep the Controls: CAPHRA's Message to Bangladesh
CAPHRA (Coalition of Asia Pacific Tobacco Harm Reduction Advocates) is advocating for a critical reassessment of Bangladesh’s proposed 20...
Read more →Cognitive Rx: A simple breathing technique that may strengthen the aging brain
Researchers at Rutgers University have unveiled compelling evidence that resonance breathing, characterized by a controlled rhythm of app...
Read more →Pain and the brain: Could this psychological therapy lead to quicker recovery from chronic back pain?
A recent study published in JAMA Network Open by a research team led by Yoni Ashar has unveiled promising insights into the treatment of ...
Read more →Why Ozempic doesn’t work for everyone: Scientists just found a hidden reason
A recent study from Stanford Medicine has identified genetic variants linked to a phenomenon termed GLP-1 resistance, which may explain w...
Read more →Fight Aging! Newsletter, April 13th 2026
A multi-phase clinical trial is set to investigate the optimal dosing of rapamycin for anti-aging applications, spearheaded by an academi...
Read more →How aggressive breast cancer turns off the immune system
Researchers at the Instituto de Tecnologia Química e Biológica António Xavier of NOVA University of Lisbon are launching the BRIDGE proje...
Read more →Hidden weak spots in HIV and Ebola revealed with breakthrough nanodisc technology
Researchers at the Scripps Research Institute have developed a novel nanodisc technology that allows for the study of viral proteins in a...
Read more →Mental health in the peri-hospital period of older patients: the roles of physical symptoms burden and sleep quality
A recent prospective study involving 683 older patients (average age 77.3) hospitalized in acute medical units highlights the detrimental...
Read more →Frailty index predicts the risk of 17 health outcomes in distinct ways: prospective findings from the Moli-sani Study
A recent analysis of data from the Moli-sani Study involving 20,975 adults has elucidated the significant relationship between frailty an...
Read more →Evaluating the impact of medication review and deprescribing on prescribing appropriateness and clinical outcomes in older people residing in long-term care facilities: a systematic review and meta-analysis
A recent systematic review and meta-analysis has highlighted the impact of medication review and deprescribing interventions on polypharm...
Read more →Effects of a 24-week resistance exercise program on Alzheimer’s disease brain signatures in cognitively unimpaired older adults: a secondary analysis of the AGUEDA randomized controlled trial
A recent study investigates the impact of a 24-week resistance exercise (RE) program on Alzheimer’s disease (AD) brain signatures in cogn...
Read more →Acceptability, appropriateness and costs of a tailored implementation strategy for the national falls prevention recommendations in Norwegian municipalities—a process evaluation of the FALLPREVENT trial
A recent cluster-randomized trial conducted in Norwegian municipalities evaluated a tailored implementation strategy for falls prevention...
Read more →